SEC Filing Summary: Midatech Pharma PLC (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Midatech Pharma PLC, a foreign private issuer, for the month of December 2016. The filing date is December 20, 2016. The registrant is headquartered in Abingdon, Oxfordshire, United Kingdom. Note: The request metadata references "Biodexa Pharmaceuticals Plc," but the filing text explicitly identifies the registrant as "Midatech Pharma PLC."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a specific corporate event via an attached press release and does not contain financial statements or performance metrics.
Material Changes
The filing discloses a material event regarding corporate governance: the submission of a press release dated December 20, 2016, entitled "Director/PDMR Shareholding." This indicates changes or disclosures related to the shareholdings of Directors and Persons Discharging Managerial Responsibilities (PDMR). No other material changes to operations or financial status are detailed in the text.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The content is limited to the administrative disclosure of the attached exhibit regarding shareholding.
Key Facts for Investor Verification
- Verify the specific details of the "Director/PDMR Shareholding" changes referenced in Exhibit 99.1, as the filing text only cites the existence of the press release.
- Confirm the identity of the registrant as Midatech Pharma PLC, distinct from the name mentioned in the request metadata.
- Note that this filing contains no financial data; investors should refer to the company's Form 20-F or interim reports for financial performance.